Masaki Terabe - Center for Cancer Research, National Cancer Institute

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 226 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Comparative Evaluation of CAR-expressing T-, NK-, NKT-cells, and Macrophages in an Immunocompetent Mouse Glioma Model

Ryusuke Hatae, Payal B Watchmaker,Akane Yamamichi,Keith Kyewalabye,Kaori Okada, Su Phyu, Yitzhar Goretsky, Jeffrey Haegelin, Psalm Pineo-Cavanaugh, Marco Gallus, Lan Phung, Tiffany Chen, Haoyu Long, Pavlina Chuntova, David H Raulet,Masaki Terabe,Hideho Okada

Neuro-oncology advancesno. 1 (2025): vdaf074-vdaf074

Cited0Views0WOSBibtex

Glioblastoma-enriched Glycosphingolipids Modulate the Function of Human Inkt Cells

Morgan J Coombs, Tyrone Dowdy, Md Masud Alam, Helena Muley Vilamú, Seketoulie Keretsu, Guzal Khayrullina,Orieta Celiku, Alexander Y Mitrophanov,Vibhuti Joshi,Jinkyu Jung, Ayaka Hara, Emily E Steffke, Laila Latifi, Hye Kim, Jo Spurgeon, Nargis Malik, John C Hancock, Byram H Ozer,Mark R Gilbert,Jenny Gumperz,Mioara Larion,Masaki Terabe

Neuro-oncology (2025)

Cited0Views0WOSBibtex

Preface: NKT Cells for Tumor Immunotherapy

Masaki Terabe, Vipin Kumar

Critical reviews in oncogenesisno. 1 (2024): ix-x

Cited0Views0WOSBibtex

GLIOBLASTOMA ENRICHED GLYCOSPHINGOLIPIDS MODULATE THE FUNCTION OF HUMAN INKT CELLS

Morgan Coombs,Tyrone Dowdy, Md Masud Alam, Guzal Khayrullina,Vibhuti Joshi, Seketoulie Keretsu,Jinkyu Jung, Ayaka Hara, Emily Steffke, Laila Latifi, Hye Kim, Jo Spurgeon, Nargis Malik, John Hancock, Kelsey Smith,Jenny Gumperz,Mioara Larion,Masaki Terabe

NEURO-ONCOLOGY (2024)

Cited0Views0Bibtex

835 Heterologous Prime Boost Viral Vector Vaccination Provides Protection Against Intracranial Syngeneic Murine Glioblastoma

Mark Gilbert,Wei Zhang,Hideho Okada,Masaki Terabe,Gary Kohanbash,Hua Song,Dionne Davis,James McAuliffe,Laurine Noblecourt, Emily E Steffke,Taijun Hana, Laila Latifi,Vinnycius Pereira Almeida,Amanda Wicki, Morgan Coombs, Nargis Malik,Meili Zhang,Nicole Briceno,Carol Leung,Benoit Van den Eynde

Journal for ImmunoTherapy of Cancerno. Suppl 1 (2023)

Cited0Views0Bibtex

Supplementary Figure 3 from Β-Mannosylceramide Activates Type I Natural Killer T Cells to Induce Tumor Immunity Without Inducing Long-Term Functional Anergy

Jessica J. O'Konek,Shingo Kato,Satomi Takao,Liat Izhak, Zheng Xia,Petr Illarionov,Gurdyal S. Besra,Masaki Terabe,Jay A. Berzofsky

openalex（2023）

Cited0Views0Bibtex

Supplementary Figure 2 from Β-Mannosylceramide Activates Type I Natural Killer T Cells to Induce Tumor Immunity Without Inducing Long-Term Functional Anergy

Jessica J. O'Konek,Shingo Kato,Satomi Takao,Liat Izhak, Zheng Xia,Petr Illarionov,Gurdyal S. Besra,Masaki Terabe,Jay A. Berzofsky

openalex（2023）

Cited0Views0Bibtex

Supplemental Figure S3 from CD47 in the Tumor Microenvironment Limits Cooperation Between Antitumor T-cell Immunity and Radiotherapy

David R. Soto-Pantoja,Masaki Terabe,Arunima Ghosh,Lisa A. Ridnour,William G. DeGraff,David A. Wink,Jay A. Berzofsky,David D. Roberts

openalex（2023）

Cited0Views0Bibtex

Supplementary Figure 1 from Β-Mannosylceramide Activates Type I Natural Killer T Cells to Induce Tumor Immunity Without Inducing Long-Term Functional Anergy

Jessica J. O'Konek,Shingo Kato,Satomi Takao,Liat Izhak, Zheng Xia,Petr Illarionov, Gurdyal S. Besra,Masaki Terabe,Jay A. Berzofsky

openalex（2023）

Cited0Views0Bibtex

Supplementary Results from Expression of CD14, IL10, and Tolerogenic Signature in Dendritic Cells Inversely Correlate with Clinical and Immunologic Response to TARP Vaccination in Prostate Cancer Patients

Luciano Castiello,Marianna Sabatino, Jiaqiang Ren,Masaki Terabe,Hanh Khuu,Lauren V. Wood,Jay A. Berzofsky, David F. Stroncek

openalex（2023）

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn